Correspondingly, ALK1 is a well-known cancer driver which could act as a tumor suppressor or oncogene, depending on the cancer type, cell type, or ligand involved28 and is an emerging target for antiangiogenic therapy of cancer29. The gene discussed is ACVRL1; the disease is neoplasm.